Sernova Corp. (OTCMKTS:SEOVF) Short Interest Up 38.2% in March
Should You Buy or Sell Sernova Stock? Get The Latest SEOVF Stock Forecast, Price Target, Earnings Estimates, and Headlines at MarketBeat.
Stay updated with breaking news from Cell Pouch. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Should You Buy or Sell Sernova Stock? Get The Latest SEOVF Stock Forecast, Price Target, Earnings Estimates, and Headlines at MarketBeat.
Sernova Corp. (OTCMKTS:SEOVF – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 31st, there was short interest totalling 161,800 shares, an increase of 38.2% from the March 15th total of 117,100 shares. Based on an average trading volume of 48,000 shares, the days-to-cover […]
Alnylam Pharmaceuticals (NASDAQ:ALNY – Get Rating) and Sernova (OTCMKTS:SEOVF – Get Rating) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings and profitability. Profitability This table compares Alnylam Pharmaceuticals and Sernova’s net margins, return […]
ISS, an independent, third-party proxy advisory firm, recommends Sernova's shareholders vote FOR all management's director nominees using ONLY management's WHITE proxy.ISS notes the dissidents failed to
08.03.2023 - Issuer: Sernova Corp. / Key word(s): Study/Study results Sernova Announces Initial Islet Transplantation in First Two Patients Enrolled in Second Cohort of its U.S. Phase 1/2 Clinical Trial for Treatment of Type 1 Diabetes 08.03.2023 / 13:05 ... Seite 1